LKA651

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LKA651, covering 2015-12-11 to 2023-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema [Phase 2]